Oesophageal cancers (adenocarcinomas [AC] and squamous cell carcinomas [SCC]) are characterized by high incidence/mortality in many countries. We aimed to delineate its global incidence and mortality, and studied whether socioeconomic development and its incidence rate were correlated. The agestandardized rates (ASRs) of incidence and mortality of this medical condition in 2012 for 184 nations from the GLOBOCAN database; national databases capturing incidence rates, and the WHO mortality database were examined. Their correlations with two indicators of socioeconomic development were evaluated. Joinpoint regression analysis was used to generate trends. The ratio between the ASR of AC and SCC was strongly correlated with HDI (r = 0.535 [men]; r = 0.661 [women]) and GDP (r = 0.594 [men]; r = 0.550 [women], both p < 0.001). Countries that reported the largest reduction in incidence in male included Poland (Average Annual Percent Change [AAPC] = −7.1, 95%C.I. = −12,−1.9) and Singapore (AAPC = −5.8, 95%C.I. = −9.5,−1.9), whereas for women the greatest decline was seen in Singapore (AAPC = −12.3, 95%C.I. = −17.3,−6.9) and China (AAPC = −5.6, 95%C.I. = −7.6,−3.4). The Philippines (AAPC = 4.3, 95%C.I. = 2,6.6) and Bulgaria (AAPC = 2.8, 95%C.I. = 0.5,5.1) had a significant mortality increase in men; whilst Columbia (AAPC = −6.1, 95%C.I. = −7.5,−4.6) and Slovenia (AAPC = −4.6, 95%C.I. = −7.9,−1.3) reported mortality decline in women. These findings inform individuals at increased risk for primary prevention.
it should be possible to control this disease by preventive measures 7 . Therefore, it is important to examine its updated rates of incidence and mortality, particularly with respect to temporal trends.
Prior evaluations studying its global trends are based on figures in late 1990s [6] [7] [8] ; have not taken country-specific socioeconomic development when the trends were compared [6] [7] [8] [9] , or compared the incidence/mortality trends in one or few selected years 10 . It remains unknown whether the effect of socioeconomic status on the development of SCC vs. AC is different in different countries. In some western countries surveillance of Barrett's esophagus is offered, though a tiny fraction of the total burden of oesophageal cancer arises from Barrett's esophagus.
This study aimed to analyze its global patterns and temporal trends of oesophageal cancer by retrieval of data from national databases. We examined the incidence ratio between AC and SCC and its correlation with socioeconomic development across various countries on a global basis.
Methodology
Data retrieval. Estimates of incidence and mortality rates of oesophageal cancer were collected from the GLOBOCAN database for 2012 1 . The disease coding is ICD-10 C15. We used a study approach similar to recent evaluations on prostate, liver, bladder and pancreatic cancer [11] [12] [13] [14] . Figures of the Gross Domestic Product (GPD) and Human Development Index (HDI) for each nation were obtained 15 , and incidence/mortality figures from GLOBOCAN of the same year 1 . HDI is determined by income per capita, period of education and life expectancy 15 . We extracted data from various sources, and restricted to those databases with no less than 15 calendar years of incidence/mortality figures. For incidence data, we retrieved country-specific registries based on the Cancer Incidence in Five Continents (CI5) volumes I-X 16 . With an aim to obtain the most updated figures, we used data from the United States 17 and Europe (European Cancer Observatory and NORDCAN) which are publicly available 18, 19 . These databases, including GLOBOCAN, have been used extensively in studies examining the incidence trends of various cancers on a global basis (Supplementary Table 1 ). Data provided by these databases are comprehensive, and have been recognized as the standards for quality among cancer registries 1, [17] [18] [19] [20] [21] [22] . Supplementary Table 2 shows the methods by which the data were obtained and their quality. Based on the International Classification of Diseases 10 th revision (ICD-10 C15), we categorized incidence data into various groups. Data on mortality were categorized using ICD 9 th (150·0) up to 1991 and 10 th version (C15) thereafter. The incidence of AC and SCC in 2012 was obtained based on the ICD for Oncology-3 presented in CI5 10, 16, 23 : ACs: 8140-8141, 8143-8145, 8190-8231, 8260-8263, 8310, 8401, 8480-8490, 8550-8551, 8570-8574, 8576; SCC: 8050-8078 and 8383-8084. To obtain mortality figures, the WHO mortality data series were used. We only included data with quality that reached medium level or above 24 , so that complete and accurate data with wide coverage could be analyzed. The database used death certificates to ascertain causes of death. The ASRs were based on the standard population of the world 25 . More developed nations were defined as European nations, New Zealand, Australia and Northern America as well as Japan, while other countries and regions were considered as less developed nations 1 .
Study Design.
To correlate rates of incidence and mortality vs. the socioeconomic indices (HDI/GDP per capita), a cross-sectional association study was performed. To examine the incidence/mortality trends in various nations based on Average Annual Percent Change (AAPC), we adopted a retrospective review of published age-standardized incidence/mortality rates from international or national data registries by joinpoint regression.
Statistical Analysis. The ASRs of incidence and mortality, as well as the AC: SCC incidence ratios of each country 10 were correlated with the two socioeconomic indicators. We used simple linear regression and examined the goodness-of-fit, which were represented by correlation coefficients. We employed regression analysis via joinpoints to evaluate the trends of incidence/mortality 26 . We conducted logarithmic transformation of the incidence/mortality rates and calculated standard errors approximated binomially. We specified a maximum of 3 joinpoints was specified as the analysis option. The intervals of average annual percentage change (AAPC) were evaluated. We calculated the AAPC as an average of APCs by geometric weighting. Weights equal to the length of each segment were assigned for the time interval specified 27 . We compared the magnitude of AAPC with zero which could generate the statistical significance of AAPC, and we defined a trend as stable if the AAPC was insignificant. We considered all p values < 0·05 as reaching statistical significance. This study obtained ethics approval from the Survey and Behavioral Research Ethics Committee of CUHK.
Results
Incidence, mortality and histologic subtype ratios of esophageal cancer. In 2012, there were 455,784 new diagnoses of oesophageal cancer and 400,169 mortality related to the cancer (Tables 1/ and 2) . Around 81% of incident cases and 82% of all mortality were reported in underdeveloped nations. Rates of incidence and mortality were greater in relatively less resourced regions than less deprived countries by 1·5 to 1·7fold in men, and by 3·4 to 4-fold in women. On a global basis, the rates of incidence varied by 20-fold. Among male, the highest rates of incidence were reported in Eastern Asia (with ASR = 16·9 per 100,000), Southern Africa (13·7), Eastern Africa (11·9) and Northern Europe (8·1), and the lowest in Western Africa (0·8), Central America (1·7), Northern Africa (2·4) and Western Asia (2·9) ( Table 1 ). In female individuals, the greatest rates were reported in middle Africa (ASR per 10,000 = 7·8), Western Africa (6·7), Eastern Asia (5·4) and Eastern Africa (4·2), while the lowest in Micronesia/Polynesia (0·2), Southern Europe (0·6), Central America (0·6) and South-Eastern Asia (1·0). The results were shown in Table 2 .
In 2012, the variation of rates of mortality was approximately 10-fold on a global basis. In male, the highest rate of mortality were estimated in the Eastern Asia (14·1), Western Africa (12·8) and middle Africa (11·2); while in female, the highest death rate was observed in these three regions (ASR of mortality = 4·5, 6·2 and 7·3 per 100,000, respectively). The lowest rates of mortality were reported in Central America (1·6), Southern Africa (2·3), and Western Asia (2·7) in men. For women, Central America (0·5) and South-Eastern Asia (0·9) reported the lowest rates of mortality. Regions with the largest incidence: mortality ratio in men included Southern Africa (1·47), Western Europe (1·27), and South America (1·23). In women, the highest ratios were reported for female in Western Europe (3·57), Northern Europe (1·63) and South America (1·34). Table 3 shows the ratio between the incidence of AC and SCC in all countries where data were available 10 . The AC:SCC ratios were in general higher in male individuals. Countries in Eastern and South-East Asia, as well as sub-Saharan Africa had low AC:SCC ratios. When compared with SCC, many countries in the Northern America (e.g. Canada, the US), Northern Europe and Western Europe such as the Netherlands, UK, and Ireland had larger incidence of AC in men.
Correlation: rates of incidence/mortality vs. HDI and GDP per capita. The incidence of AC increased with HDI in men (r 2 = 0·224, r = 0·473) and women (r 2 = 0·037, r = 0·192), and similarly for its relationship with GDP (r 2 = 0·288, r = 0·537 and r 2 = 0·0716, r = 0·268 for male and female, respectively). For SCC, its incidence was inversely correlated with HDI (r 2 = 0·051, r = −0·226, p = 0·004 for men; r 2 = 0·098, r = −0·313, p < 0·001 for women) and GDP per capita (r 2 = 0·040, r = −0·200, p = 0·012 for men; r 2 = 0·0437, r = −0·209, p = 0·009 for women) ( Fig. 1A to D). HDI was correlated with the ratio between the standardized incidence of AC and SCC (r² = 0·287, r = 0·535 [men]; r² = 0·437, r = 0·661 [women]) and GDP per capita (r² = 0·353, r = 0·594 [men]; r² = 0·302, r = 0·550 [women], all p < 0·001). Similar trend was observed when the ratio between the absolute incidence of AC and SCC was used ( Fig. 2A to D). Time trends. The global trends of incidence and mortality according to gender were shown in Supplementary   Figure 1 . Among male subjects, 3 countries reported increasing incidence, 7 countries reported decreasing incidence, and 31 countries had stable rates of incidence. Among women, one country showed increasing incidence and 4 showed declining incidence. Turning to mortality rates, 2 countries had increasing trends, 10 countries reported decreasing male mortality and 29 nations reported relatively stable time trends in male subjects. Five countries had decreasing death rates and 36 countries had stable death rates in female populations.
Latin America/the Caribbean. All countries in this continent had stable incidence trends in the past decade of analysis (Fig. 3A) . The ASR mortality rate reported a decline in Brazilian men (AAPC −1.2, 95% C.I. −1.5, −0.8)
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Incidence to mortality ratio n ASR n ASR and women (AAPC −1.6, 95% C.I. −2.3, −0.9). Columbia also had a significant reduction in mortality among men (AAPC −4.6, 95% C.I. −5.8, −3.4) and women (AAPC −6.1, 95% C.I. −7.5, −4.6) ( Fig. 3B ). Oceania. The incidence decreased in Australia in female subjects (AAPC −2·5, 95% C.I. −3·8, −1·2). All other trends were stable.
Northern Europe. Only the United Kingdom (AAPC 1·4, 95% C.I.0·9, 1·9) and Denmark (AAPC 2.9, 95% C.I. 1.1, 4.7) reported an incidence increase among male. The United Kingdom also showed a mortality reduction among both male (AAPC −0·6, 95% C.I. −0·9, −0·3) and female (AAPC −1·6, 95% C.I. −2·2, −1·1). The majority of the countries had stable incidence and mortality rates.
Western Europe. The incidence rate was found to increase in the Netherlands in male populations (AAPC 3, 95% C.I. 2, 4) and female (AAPC 2·3, 95% C.I. 1·3, 3·2) individuals. France reported a decline in incidence (AAPC −3·7, 95% C.I. −5, −2·5) and mortality rates (AAPC −3·4, 95% C.I. −3·9, −2·9) among men.
Southern Europe. Italy and Croatia were two countries that had declines in incidence and mortality rates in male populations. Slovenia showed a decline in mortality among women (AAPC −4·6, 95% C.I. −7·9, −1·3). 
Discussion
This study evaluated the worldwide incidence/mortality rates of oesophageal cancer based on existing data. It was found that the incidence and mortality showed wide variations on a global basis. In men, Eastern Asia, Southern Africa and Eastern Africa had the highest number of new diagnoses -mostly SCC. The greatest mortality in male was found in Middle Africa, Western Africa and Eastern Asia. The highest incidence: mortality ratio was reported in Northern and Southern Africa among male, while in Western Europe and Southern America among female. We found that HDI and GDP per capita were both correlated with AC:SCC ratios in incidence. The correlation coefficients for HDI and GPD per capita for the incidence of oesophageal cancer are large. One of the important findings includes the incidence decline in Black America, Singapore and China in men and women. In men, mortality rates increased drastically in less developed nations including the Philippines and Bulgaria. In women, a substantial decrease in mortality was reported for Columbia and Slovenia.
Findings from the present study corroborate those of previous literature. Populations in Asia such as Northern Iran 28 , Central Asia and China 29 , as well as Eastern Africa [30] [31] [32] , have high incidence rates -so that these regions were collectively named as the "oesophageal cancer belt" 10 . The higher incidence rates in these regions may reflect the changing epidemiology of the two histologic types of esophageal cancer (SCC vs. AC) in recent years, such as in Iran where the rates of AC were among the highest in the Central Asian region, particularly in women 33 . Some nations reported greater rates of AC when compared with that of SCC, including Northern/Western Europe and Northern America.
This study showed that nations with higher socioeconomic developement had higher AC:SCC ratio in correlation analyses. Poor oral hygiene and poverty have been associated with a higher SCC risk. In addition, there has been rising prevalence of obesity (a risk factor for AC) 10 but declining tobacco smoking (risk of SCC) in more developed nations, which may underpin these correlation trends. Probable explanations for the reduction of mortality trends may consist of technological advancement of oesophageal cancer, such as improvements in endoscopic detection and therapy for early stage disease. These consist of minimally invasive esophagectomy 3 -which when accompanied by a strategy with conjoint use of laparoscopic and thoracoscopic techniques, can lead to a very low rate of postoperative mortality (1.7% showed escalating rates of cancer death in women. This observation could be explained by the capacities and accessibility of healthcare services which are crucial for early diagnosis and management. The exact reasons on the rise of mortality rates in these countries are yet to be explored. It should be noted that the AC:SCC ratio only exceeded 1 in men in most developed nations. SCC was still a predominate type of oesophageal cancer as reported in this study. Arnold and colleagues 10 previously analyzed the total numbers of AC and SCC in 2012, and reported that SCC was a disproportionally common histologic type when compared to AC on a global basis. This study updated the incidence and mortality of oesophageal cancer, and explored its time trends and global variability by high quality data from recognized databases. Nonetheless, this study has some limitations. Firstly, cancer diagnoses could be under-reported and may induce bias in cancer registration, particularly in nations where resources are limited 29 . On the other hand, in nations where figures were derived from only one cancer registry situated in more developed areas, the estimates might have overestimated the real figures especially in those countries with large areas of underdeveloped regions. Also, less than half of the world's nations provided high quality incidence/mortality data. Therefore, the incidence and mortality figures could have a certain degree of bias, especially in underprivileged nations. In summary, the incidence of esophageal cancer decreased in the majority of nations, yet the death rates in male populations increased in some countries, especially in the Portugal and Bulgaria. With global expansion in population size, a further increase in its global health burden could be huge -particularly adenocarcinoma that is positively correlated with socioeconomic development. Therefore, more expenditure will be required to sustain its diagnosis and treatment. In the community, more resources should also be committed to primary prevention strategies.
